<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03540459</url>
  </required_header>
  <id_info>
    <org_study_id>Les Grands Prés</org_study_id>
    <nct_id>NCT03540459</nct_id>
  </id_info>
  <brief_title>Central Apnea in Patients Receiving Ticagrelor</brief_title>
  <official_title>Central Apnea in Patients Receiving Ticagrelor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Les Grands Prés</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Les Grands Prés</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      all patients with a left ventricular ejection fraction superior or equal to 50% less than 2
      years after an acute coronary event and receiving ticagrelor will undergo a sleep polygraphy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      all patients with a left ventricular ejection fraction superior or equal to 50% less than 2
      years after an acute coronary event and receiving ticagrelor will undergo a sleep polygraphy
      the main objective of the study will be to look for central sleep apnea
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>central apnea index</measure>
    <time_frame>at baseline</time_frame>
    <description>mean central apnea index: apnea hypopnea index (AHI) is the scale commonly used to assess sleep disordered breathing.This scale includes central and obstructive apnea and hypopnea. The main outcome will be the central apnea index: number of central apnea per hour</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>global apnea hypopnea index</measure>
    <time_frame>baseline</time_frame>
    <description>number of apnea and hypopnea per our</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>sleep polygraphy</intervention_name>
    <description>sleep polygraphy (one night) in all included patients</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patient receiving ticagrelor 10 days to 2 years after an acute coronary syndrome will
        be included
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient receiving ticagrelor 10 days to 2 years after an acute coronary syndrome

        Exclusion Criteria:

          -  left ventricular ejection fraction &lt; 50%

          -  patients refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>philippe meurin, MD</last_name>
    <phone>+33674003218</phone>
    <email>philippemeurin@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>jean yves Tabet</last_name>
    <phone>0033608352073</phone>
    <email>jtabet@free.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Les Grands Prés</name>
      <address>
        <city>Villeneuve Saint Denis</city>
        <zip>77174</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Meurin, MD</last_name>
      <phone>0674003218</phone>
      <email>philippemeurin@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Helene Weber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 16, 2018</study_first_submitted>
  <study_first_submitted_qc>May 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2018</study_first_posted>
  <last_update_submitted>February 5, 2020</last_update_submitted>
  <last_update_submitted_qc>February 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Les Grands Prés</investigator_affiliation>
    <investigator_full_name>philippe meurin</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea, Central</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

